(Q37636513)

21 August 2017

1 reference

title

High-density lipoprotein: a potent inhibitor of inflammation (English)

1 reference

21 August 2017

0 references

0 references

1 reference

2

1 reference

21 August 2017

Andrew J Murphy

1

1 reference

21 August 2017

publication date

21 November 2009

1 reference

Clinical and Experimental Pharmacology and Physiology

21 August 2017

published in

1 reference

21 August 2017

volume

37

1 reference

21 August 2017

issue

7

1 reference

21 August 2017

page(s)

710-718

1 reference

Scavenger receptor class B type I-mediated cholesteryl ester-selective uptake and efflux of unesterified cholesterol. Influence of high density lipoprotein size and structure

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2009.05338.X

Acute effects of intravenous infusion of ApoA1/phosphatidylcholine discs on plasma lipoproteins in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2009.05338.X

HDL3-mediated inhibition of thrombin-induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinositide-derived second messengers 1,2-diacylglycerol and inositol 1,4,5-tris-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2009.05338.X

High density lipoprotein modulates platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2009.05338.X

Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2009.05338.X

10.1111/J.1440-1681.2009.05338.X

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference